Gómez-Escobar, Luis G.
Hoffman, Katherine L.
Choi, Justin J.
Borczuk, Alain
Salvatore, Steven
Alvarez-Mulett, Sergio L.
Galvan, Manuel D.
Zhao, Zhen http://orcid.org/0000-0002-9742-5982
Racine-Brzostek, Sabrina E. http://orcid.org/0000-0002-6296-6682
Yang, He S.
Stout-Delgado, Heather W.
Choi, Mary E. http://orcid.org/0000-0002-6853-336X
Choi, Augustine M. K.
Cho, Soo Jung
Schenck, Edward J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (KL2-TR-00238, R01 AG052530, R01 AG056699, R01 HL055330, K08 HL138285, KL2 TR000458-10)
Article History
Received: 7 December 2020
Accepted: 26 May 2021
First Online: 15 June 2021
Competing interests
: AMKC is a cofounder, stock holder and serves on the Scientific Advisory Board for Proterris Inc., which develops therapeutic uses for carbon monoxide (CO). AMKC also has a use patent (7,678,390; carbon monoxide as a biomarker and therapeutic agent) on CO. The spouse of MEC is a cofounder and shareholder and serves on the Scientific Advisory Board of Proterris Inc.